⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Brenda Matti-OrozcoM.D.

Internal Medicine · Morristown, NJ 07960

NPI: 1366435216

Share:

38

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

1,902

Total Claims

$156K

Drug Cost

246

Beneficiaries

$633

Cost/Patient

Risk Score Breakdown 38/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+1457%

Opioid rate vs peers

34.9% vs 2.2% avg

-55%

Cost per patient vs peers

$633 vs $1,411 avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 1,457% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

34.9%

Opioid Rate

663

Opioid Claims

$68K

Opioid Cost

32.4%

Long-Acting Rate

This provider's opioid prescribing rate of 34.9% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 1,623 claims · $53K

Patient Profile

71

Avg Age

56%

Female

2.43

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About